- Home
- TRVI vs ARL Comparison
TRVI vs ARL Comparison
Compare TRVI & ARL Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- TRVI
- ARL
- Stock Information
- Founded
- TRVI 2011
- ARL 1999
- Country
- TRVI United States
- ARL United States
- Employees
- TRVI N/A
- ARL N/A
- Industry
- TRVI Biotechnology: Pharmaceutical Preparations
- ARL Building operators
- Sector
- TRVI Health Care
- ARL Real Estate
- Exchange
- TRVI Nasdaq
- ARL Nasdaq
- Market Cap
- TRVI 211.4M
- ARL 231.0M
- IPO Year
- TRVI 2019
- ARL N/A
- Fundamental
- Price
- TRVI $2.75
- ARL $13.91
- Analyst Decision
- TRVI Strong Buy
- ARL
- Analyst Count
- TRVI 8
- ARL 0
- Target Price
- TRVI $9.13
- ARL N/A
- AVG Volume (30 Days)
- TRVI 659.5K
- ARL 17.7K
- Earning Date
- TRVI 11-06-2024
- ARL 11-07-2024
- Dividend Yield
- TRVI N/A
- ARL N/A
- EPS Growth
- TRVI N/A
- ARL N/A
- EPS
- TRVI N/A
- ARL N/A
- Revenue
- TRVI N/A
- ARL $51,029,000.00
- Revenue This Year
- TRVI N/A
- ARL N/A
- Revenue Next Year
- TRVI N/A
- ARL N/A
- P/E Ratio
- TRVI N/A
- ARL N/A
- Revenue Growth
- TRVI N/A
- ARL 0.87
- 52 Week Low
- TRVI $0.97
- ARL $12.51
- 52 Week High
- TRVI $4.00
- ARL $25.96
- Technical
- Relative Strength Index (RSI)
- TRVI 37.52
- ARL 41.73
- Support Level
- TRVI $2.80
- ARL $13.37
- Resistance Level
- TRVI $3.22
- ARL $15.85
- Average True Range (ATR)
- TRVI 0.20
- ARL 0.76
- MACD
- TRVI -0.03
- ARL 0.01
- Stochastic Oscillator
- TRVI 14.68
- ARL 29.26
About TRVI Trevi Therapeutics Inc.
Trevi Therapeutics Inc is a clinical-stage biopharmaceutical company focused on the development and commercialization of the investigational therapy Haduvio (oral nalbuphine ER) for the treatment of chronic cough in adults with idiopathic pulmonary fibrosis, or IPF, and other chronic cough indications, and for the treatment of prurigo nodularis. Haduvio is an oral extended-release formulation of nalbuphine.
About ARL American Realty Investors Inc.
American Realty Investors Inc is a real estate company. The company acquires, develops, and owns income-producing residential and commercial real estate properties. Its segment involves the Residential segment and the Commercial segment. The residential segment is engaged in the acquisition, development, ownership, and management of multifamily properties and the Commercial segment is engaged in the acquisition, ownership, and management of commercial real estate properties. Its holdings include apartments, office buildings, retail centers, and parcels of land.